Sean Sheridan, Ph.D. is a Vice President in the Intellectual Property Practice at Charles River Associates. He provides financial consulting services for a variety of purposes including transaction due diligence, license negotiation support, and litigation. The engagements he has worked on span a wide range of industries and products, including pharmaceuticals, recombinant therapeutic proteins, vaccines, gene editing, medical devices, diagnostics, research tools, electronic health records, and many others outside of the life sciences. He is a frequent speaker and instructor on intellectual property valuation and has been named to the IAM Patent 1000: The World’s Leading Patent Professionals (economic experts) every year since 2019.